,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,levosimendan group,dobutamine group,,,,
0,mean survival over 6 months,157+/-52 days,139+/-64 days,NR,NR,P < 0.01,NR
